ArticleEuropean journal of immunology2026
Hypoxia Independently Induces AID Expression in CH12 B Cells.
Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low hypoxia tolerance as a determinant of the proinflammatory phenotype: a trained immunity perspective.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hypoxia has been shown to shape the humoral immune response within germinal centers, where B cells diversify their receptors through somatic hypermutation (SHM) and class switch recombination (CSR). Both processes are initiated by activation-induced cytidine deaminase (AID), which deaminates cytosines into uracils in immunoglobulin genes, leading to point mutations during SHM or to double-stranded DNA breaks during CSR. Although AID's function is well characterized, the mechanisms governing its expression remain ill-defined. We previously identified the hypoxia-inducible transcription factor (HIF) transcription complex (comprised of HIF-1α, HIF-1β, and the auxiliary subunits HIF-2α and HIF-3α) as a regulator of optimal AID expression during CSR. Indeed, loss of HIF-1α or HIF-1β delays AID expression and impairs CSR. Here, we examine the contribution of HIF-2α and HIF-3α. We show that deficiency in HIF-2α, but not HIF-3α, impairs CSR, whereas combined loss of HIF-1α and HIF-2α does not exacerbate the defect, indicating that HIF-1α is the dominant subunit driving this process. Importantly, we demonstrate that hypoxia can induce AID expression, independently of additional stimuli. Collectively, these findings reveal that hypoxia regulates AID expression in a context- and time-dependent manner through HIF activation. This underscores the central role of hypoxic signaling in antibody diversification and suggests broader implications for immune regulation and the onset of B-cell malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.